E Voigt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E Voigt

Showing results (41-50 of 50) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 50 results.

Chirurgisches Forum Fur Experimentelle Und Klinische Forschung|January 1, 1980

[Influence of left atrial pressure on left ventricular function after extracorporeal circulation (author's transl)]W Seybold-Epting, C Huth, K van Deyk, et al.

Zeitschrift Fur Gastroenterologie|March 20, 2001

Cutaneous manifestations in inflammatory bowel diseaseA Tromm, D May, E Almus, et al.

European Journal of Clinical Pharmacology|August 11, 2007

Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicityJ-C Wasmuth, I Lambertz, E Voigt, et al.

Infection|April 2, 2004

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week resultsE Voigt, J-C Wasmuth, M Vogel, et al.

Tissue Engineering. Part C, Methods|June 5, 2013

Three-dimensional microfluidic collagen hydrogels for investigating flow-mediated tumor-endothelial signaling and vascular organizationCara F Buchanan, Elizabeth E Voigt, Christopher S Szot, et al.

European Journal of Medical Research|October 16, 2007

Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoringJ-C Wasmuth, E Rodermann, E Voigt, et al.

Anesthesia & Pain Control in Dentistry|January 1, 1992

Protocol for studying depth of anesthesia using the spectral edge frequencyM V Schaefer, M S Rugeles, G Gurman, et al.

HIV Medicine|November 26, 2002

First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week resultsE Voigt, A Wickesberg, J-C Wasmuth, et al.

Anesthesia and Analgesia|January 1, 1993

Postoperative voiding interval and duration of analgesia following peripheral or caudal nerve blocks in childrenQ A Fisher, C M McComiskey, J L Hill, et al.

European Journal of Medical Research|August 11, 2006

Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversionM Vogel, M Lichterfeld, D E Kaufmann, et al.

Pageof 5

Search research articles

Showing results (41-50 of 50) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 50 results.

Chirurgisches Forum Fur Experimentelle Und Klinische Forschung|January 1, 1980

[Influence of left atrial pressure on left ventricular function after extracorporeal circulation (author's transl)]W Seybold-Epting, C Huth, K van Deyk, et al.

Zeitschrift Fur Gastroenterologie|March 20, 2001

Cutaneous manifestations in inflammatory bowel diseaseA Tromm, D May, E Almus, et al.

European Journal of Clinical Pharmacology|August 11, 2007

Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicityJ-C Wasmuth, I Lambertz, E Voigt, et al.

Infection|April 2, 2004

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week resultsE Voigt, J-C Wasmuth, M Vogel, et al.

Tissue Engineering. Part C, Methods|June 5, 2013

Three-dimensional microfluidic collagen hydrogels for investigating flow-mediated tumor-endothelial signaling and vascular organizationCara F Buchanan, Elizabeth E Voigt, Christopher S Szot, et al.

European Journal of Medical Research|October 16, 2007

Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoringJ-C Wasmuth, E Rodermann, E Voigt, et al.

Anesthesia & Pain Control in Dentistry|January 1, 1992

Protocol for studying depth of anesthesia using the spectral edge frequencyM V Schaefer, M S Rugeles, G Gurman, et al.

HIV Medicine|November 26, 2002

First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week resultsE Voigt, A Wickesberg, J-C Wasmuth, et al.

Anesthesia and Analgesia|January 1, 1993

Postoperative voiding interval and duration of analgesia following peripheral or caudal nerve blocks in childrenQ A Fisher, C M McComiskey, J L Hill, et al.

European Journal of Medical Research|August 11, 2006

Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversionM Vogel, M Lichterfeld, D E Kaufmann, et al.

Pageof 5